XENETIC BIOSCIENCES, INC. (XBIO) Operating cash flow 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.3MFY2025 · since FY2016: -$8.8M → -$2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.3M | +18.8% |
| FY2024 | -$2.8M | +31.5% |
| FY2023 | -$4.1M | +11.5% |
| FY2022 | -$4.6M | +1.9% |
| FY2021 | -$4.7M | -11.0% |
| FY2020 | -$4.3M | +33.3% |
| FY2019 | -$6.4M | +1.0% |
| FY2018 | -$6.5M | -532.6% |
| FY2017 | $1.5M | +117.0% |
| FY2016 | -$8.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIO financial trends
XBIO RevenueXBIO Net incomeXBIO Net marginXBIO Gross profitXBIO Gross marginXBIO Operating incomeXBIO Operating marginXBIO Free cash flowXBIO Capital expendituresXBIO Return on equityXBIO Stock buybacksXBIO Dividends paidXBIO Total assetsXBIO Total liabilitiesXBIO Shareholders’ equityXBIO overview →